Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Drops By 12.5%

Cocrystal Pharma, Inc. (NASDAQ:COCP) was the recipient of a large drop in short interest in November. As of November 30th, there was short interest totalling 7,000 shares, a drop of 12.5% from the November 15th total of 8,000 shares. Based on an average daily volume of 18,600 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.1% of the company’s stock are sold short.

Cocrystal Pharma Stock Performance

Shares of Cocrystal Pharma stock opened at $1.91 on Friday. Cocrystal Pharma has a 1 year low of $1.33 and a 1 year high of $3.10. The firm’s 50-day simple moving average is $1.94 and its 200-day simple moving average is $2.02. The firm has a market cap of $19.41 million, a PE ratio of -1.03 and a beta of 1.52.

Wall Street Analyst Weigh In

Separately, HC Wainwright dropped their price target on shares of Cocrystal Pharma from $10.00 to $7.00 and set a “buy” rating for the company in a research note on Thursday, August 22nd.

About Cocrystal Pharma

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.